Product Catalog Become a Supplier Source Supplier

Product Catalog Become a Supplier Source Supplier About MAI

Search and Find the CMO / CDMO You Need

Discover highly skilled partners for your drug development and manufacturing project.

Filters

North America

Europe

APAC

MENA

LATAM

CHEMICAL-SYNTHETIC

BIOLOGICS

OLIGONUCLEOTIDES

PARTICLE ENGINEERING

FDF / DRUG PRODUCTS

COSMETICS

NUTRACEUTICALS

SERVICES

Small

Medium

Large

Investigational

Commercial (Phase IV)

Human

Veterinary

(A) Digestive tract and metabolism

(B) Blood and blood forming organs

(D) Dermatologicals

(G) Genito urinary system and sex hormones

(H) Systemic hormonal preparations excl. sex hormones and insulins

(J) Antiinfectives for systemic use

(L) Antineoplastic and immunomodulating agents

(M) Musculoskeletal system

(N) Nervous system

(P) Antiparasitic products, insecticides and repellents

(R) Respiratory system

(S) Sensory organs

(V01) Allergens

(V04) Diagnostic agents

(V06) Nutrients

(V09-10) Radiopharmaceuticals

1 / low-hazard (PDE > 10,000 µg/day)

2 (PDE = 1,000 - 10,000 µg/day)

3 (PDE = 100 - 1,000 µg/day)

4 / HPAPI (PDE = 10 - 100 µg/day)

5 / HPAPI (PDE < 10 µg/day)

Lowest potential for abuse

Low potential for abuse

Lower potential for abuse

High potential for abuse & medical use

High potential for abuse & no medical use

PMDA (Japan)

TGA (Australia)

MHRA (UK)

Health Canada

NMPA (China GMP)

ANVISA (Brazil)

ISO

World Health Organization (GMP / HACCP)

ICH

FDA (cGMP)

NSF

EMA (EU GMP)

PMDA/MHLW (Japan GMP)

NMPA (China GMP)

Health Canada (Canada GMP)

MHRA (UK GMP)

TGA (Australia GMP)

MFDS/KFDA (Republic of Korea GMP)

TITCK (Turkish Health Authorities)

UAE Ministry of Health & Prevention

SFDA (Saudi Food & Drug Authority)

ANMAT (Argentina nueva GMP)

ANVISA (Brazil B-GMP)

ISP (Chile BPM)

INVIMA

MSPAS

COFEPRIS

DIGEMID

Roszdravnadzor (Russia GMP)

IFS

SQF (Safe Quality Food)

BRCGS

Halal Research Council

ECOVADIS

French Service-Public (CIR)

Rest of World

FDA (USA)

EMA (EU)

PMDA (Japan)

NMPA (China)

MHRA (UK)

Health Canada (Canada)

TGA (Australia)

CDSCO (India)

MFDS (South Korea)

Turkish Health Authorities

EDE (UAE)

SFDA (Saudi Arabia)

ANMAT (Argentina)

ANVISA (Brazil)

ISP (Chile)

INVIMA (Colombia)

MSPAS (Guatemala)

COFEPRIS (Mexico)

DIGEMID (Peru)

Russian Health Authorities

Development services

Manufacturing services

Analytical / QC services

Quality Assurance services

Regulatory services

Packaging

Logistics

Applied Filters:Veterinary×Clear All

Showing 92 facilities

Sort by:

Limited view

COSMETICS manufacturing site

MAI network supplier

Small molecule drug substance development and manufacturing site.

Location available after registration

Previous 1 2 3 4 5 Next

…

MAI CDMO Network is your B2B platform bridging the gap between pharmaceutical and biotech companies and Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs). Find the perfect partner for your project.

INFORMATION

Privacy Policy
Legal Notice
Cookies Policy
FAQs

SERVICES

Services for Suppliers
Services for Outsourcing
Plans

CONTACT US

contact@mai-cdmo.com

Basque Technology Park, Astondo Bidea, 612, 48160, Derio, Biscay

If you have any questions or suggestions, click here to contact us. We will be happy to assist you.

Filters

North America

Europe

APAC

MENA

LATAM

CHEMICAL-SYNTHETIC

BIOLOGICS

OLIGONUCLEOTIDES

PARTICLE ENGINEERING

FDF / DRUG PRODUCTS

COSMETICS

NUTRACEUTICALS

SERVICES

Small

Medium

Large

Investigational

Commercial (Phase IV)

Human

Veterinary

(A) Digestive tract and metabolism

(B) Blood and blood forming organs

(D) Dermatologicals

(G) Genito urinary system and sex hormones

(H) Systemic hormonal preparations excl. sex hormones and insulins

(J) Antiinfectives for systemic use

(L) Antineoplastic and immunomodulating agents

(M) Musculoskeletal system

(N) Nervous system

(P) Antiparasitic products, insecticides and repellents

(R) Respiratory system

(S) Sensory organs

(V01) Allergens

(V04) Diagnostic agents

(V06) Nutrients

(V09-10) Radiopharmaceuticals

1 / low-hazard (PDE > 10,000 µg/day)

2 (PDE = 1,000 - 10,000 µg/day)

3 (PDE = 100 - 1,000 µg/day)

4 / HPAPI (PDE = 10 - 100 µg/day)

5 / HPAPI (PDE < 10 µg/day)

Lowest potential for abuse

Low potential for abuse

Lower potential for abuse

High potential for abuse & medical use

High potential for abuse & no medical use

PMDA (Japan)

TGA (Australia)

MHRA (UK)

Health Canada

NMPA (China GMP)

ANVISA (Brazil)

ISO

World Health Organization (GMP / HACCP)

ICH

FDA (cGMP)

NSF

EMA (EU GMP)

PMDA/MHLW (Japan GMP)

NMPA (China GMP)

Health Canada (Canada GMP)

MHRA (UK GMP)

TGA (Australia GMP)

MFDS/KFDA (Republic of Korea GMP)

TITCK (Turkish Health Authorities)

UAE Ministry of Health & Prevention

SFDA (Saudi Food & Drug Authority)

ANMAT (Argentina nueva GMP)

ANVISA (Brazil B-GMP)

ISP (Chile BPM)

INVIMA

MSPAS

COFEPRIS

DIGEMID

Roszdravnadzor (Russia GMP)

IFS

SQF (Safe Quality Food)

BRCGS

Halal Research Council

ECOVADIS

French Service-Public (CIR)

Rest of World

FDA (USA)

EMA (EU)

PMDA (Japan)

NMPA (China)

MHRA (UK)

Health Canada (Canada)

TGA (Australia)

CDSCO (India)

MFDS (South Korea)

Turkish Health Authorities

EDE (UAE)

SFDA (Saudi Arabia)

ANMAT (Argentina)

ANVISA (Brazil)

ISP (Chile)

INVIMA (Colombia)

MSPAS (Guatemala)

COFEPRIS (Mexico)

DIGEMID (Peru)

Russian Health Authorities

Development services

Manufacturing services

Analytical / QC services

Quality Assurance services

Regulatory services

Packaging

Logistics

Limited view

COSMETICS manufacturing site

MAI network supplier

Small molecule drug substance development and manufacturing site.

Location available after registration

Previous 1 2 3 4 5 Next